Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Abhay Chauhan PHD

Abhay Chauhan PHD

Assistant Professor

Institution: Medical College of Wisconsin
Department: School of Pharmacy
Division: Administration
Program: Program Development

Member of the Cancer Center


Publications

  • Development of a Topical Resveratrol Formulation for Commercial Applications Using Dendrimer Nanotechnology. (Pentek T, Newenhouse E, O'Brien B, Chauhan AS) Molecules 2017 Jan 14;22(1) PMID: 28098828 01/19/2017
  • Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide. (Singh MK, Pooja D, Kulhari H, Jain SK, Sistla R, Chauhan AS) Eur J Pharm Sci 2017 Jan 01;96:84-92 PMID: 27614111 10/28/2016
  • siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector. (Tekade RK, Maheshwari RG, Sharma PA, Tekade M, Chauhan AS) Curr Pharm Des 2015;21(31):4614-36 PMID: 26486147 10/22/2015
  • Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer. (Katare YK, Daya RP, Sookram Gray C, Luckham RE, Bhandari J, Chauhan AS, Mishra RK) Mol Pharm 2015 Sep 08;12(9):3380-8 PMID: 26226403 08/01/2015
  • Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol. (Chauhan AS) Ann N Y Acad Sci 2015 Aug;1348(1):134-40 PMID: 26173478 07/16/2015
  • Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics. (Tekade RK, Tekade M, Kumar M, Chauhan AS) Pharm Res 2015 Mar;32(3):910-28 PMID: 25205461 09/11/2014
  • Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation. (Kulhari H, Pooja D, Singh MK, Chauhan AS) Drug Dev Ind Pharm 2015 Feb;41(2):232-8 PMID: 24237325 11/19/2013
  • Pharmacokinetic and pharmacodynamic studies of poly(amidoamine) dendrimer based simvastatin oral formulations for the treatment of hypercholesterolemia. (Kulhari H, Kulhari DP, Prajapati SK, Chauhan AS) Mol Pharm 2013 Jul 01;10(7):2528-33 PMID: 23692066 05/23/2013
  • Development and optimization of thiolated dendrimer as a viable mucoadhesive excipient for the controlled drug delivery: an acyclovir model formulation. (Yandrapu SK, Kanujia P, Chalasani KB, Mangamoori L, Kolapalli RV, Chauhan A) Nanomedicine 2013 May;9(4):514-22 PMID: 23117047 11/03/2012
  • Performance evaluation of PAMAM dendrimer based simvastatin formulations. (Kulhari H, Pooja D, Prajapati SK, Chauhan AS) Int J Pharm 2011 Feb 28;405(1-2):203-9 PMID: 21145960 12/15/2010
  • Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers. (Chauhan AS, Diwan PV, Jain NK, Tomalia DA) Biomacromolecules 2009 May 11;10(5):1195-202 PMID: 19348417 04/08/2009
  • Dendrimers for enhanced drug solubilization. (Svenson S, Chauhan AS) Nanomedicine (Lond) 2008 Oct;3(5):679-702 PMID: 18817470 09/27/2008
  • Controlled systemic delivery of indomethacin using membrane-moderated, cream formulation-based transdermal devices. (Rao PR, Chalasani KB, Chauhan AS, Jain AK, Diwan PV, Ram MK) Drug Deliv 2006 May-Jun;13(3):207-13 PMID: 16556573 03/25/2006
  • Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient. (Asthana A, Chauhan AS, Diwan PV, Jain NK) AAPS PharmSciTech 2005 Oct 27;6(3):E536-42 PMID: 16354015 PMCID: PMC2750401 12/16/2005
  • Solubility enhancement of indomethacin with poly(amidoamine) dendrimers and targeting to inflammatory regions of arthritic rats. (Chauhan AS, Jain NK, Diwan PV, Khopade AJ) J Drug Target 2004;12(9-10):575-83 PMID: 15621683 12/29/2004
  • Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. (Chauhan AS, Sridevi S, Chalasani KB, Jain AK, Jain SK, Jain NK, Diwan PV) J Control Release 2003 Jul 31;90(3):335-43 PMID: 12880700 07/26/2003
  • Last update: 04/13/2017
    jenkins-FCD Prod-130 96200611f8481f0aa4f84230b11dd74d063847a3